BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9029020)

  • 21. Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark.
    Lauritzen AF; Specht LK; Nissen NI; Hou-Jensen K
    Dan Med Bull; 1991 Feb; 38(1):84-7. PubMed ID: 2026054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease.
    Medeiros LJ; Greiner TC
    Cancer; 1995 Jan; 75(1 Suppl):357-69. PubMed ID: 8001007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease and age.
    Specht L; Nissen NI
    Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Askergren J; Söderberg G
    Scand J Haematol; 1977 Nov; 19(5):487-95. PubMed ID: 594663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
    Rubio R
    Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular dendritic cells have prognostic relevance in Hodgkin's disease.
    Alavaikko MJ; Blanco G; Aine R; Lehtinen T; Fellbaum C; Taskinen PJ; Sarpola A; Hansmann ML
    Am J Clin Pathol; 1994 Jun; 101(6):761-7. PubMed ID: 8209866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment results of Hodgkin's lymphoma].
    Aleknavicius E; Valuckas KP; Aleknaviciene B; Norkiene L; Smailyte G
    Medicina (Kaunas); 2009; 45(8):615-23. PubMed ID: 19773620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in clinico-pathological features of Hodgkin's disease and follicular lymphoma in Nagoya, Japan, over a 21-year period (1965-85).
    Tajima K; Suchi T; Oyama A
    Acta Pathol Jpn; 1990 Oct; 40(10):713-21. PubMed ID: 2291403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages.
    von Wasielewski S; Franklin J; Fischer R; Hübner K; Hansmann ML; Diehl V; Georgii A; von Wasielewski R
    Blood; 2003 May; 101(10):4063-9. PubMed ID: 12543871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in Hodgkin's disease with special reference to age.
    Wedelin C; Björkholm M; Biberfeld P; Holm G; Johansson B; Mellstedt H
    Cancer; 1984 Mar; 53(5):1202-8. PubMed ID: 6692308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
    Xing PY; Shi YK; He XH; Zhou LQ; Dong M; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):692-7. PubMed ID: 23159084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors affecting disease-free survival in patients with Hodgkin's disease stages IA and IIA treated initially with radiotherapy alone in a single centre during 1973 to 1992.
    Bessell EM; Moloney AJ; Ellis IO; Fletcher J; Dowling F
    Radiother Oncol; 1998 Oct; 49(1):15-9. PubMed ID: 9886692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease.
    García R; Hernández JM; Caballero MD; González M; Galende J; del Cañizo MC; Vázquez L; San Miguel JF
    Br J Cancer; 1993 Dec; 68(6):1227-31. PubMed ID: 8260377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.
    Specht L; Nissen NI
    Eur J Haematol; 1988 May; 40(5):396-402. PubMed ID: 3378595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
    Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.